Does INEBILIZUMAB-CDON Cause Off label use? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Off label use have been filed in association with INEBILIZUMAB-CDON. This represents 3.7% of all adverse event reports for INEBILIZUMAB-CDON.
13
Reports of Off label use with INEBILIZUMAB-CDON
3.7%
of all INEBILIZUMAB-CDON reports
0
Deaths
6
Hospitalizations
How Dangerous Is Off label use From INEBILIZUMAB-CDON?
Of the 13 reports, 6 (46.2%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INEBILIZUMAB-CDON. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does INEBILIZUMAB-CDON Cause?
Neuromyelitis optica spectrum disorder (42)
Headache (29)
Covid-19 (21)
Pain (21)
Nausea (20)
Pneumonia (20)
Arthralgia (18)
Fatigue (17)
Urinary tract infection (17)
Product storage error (14)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which INEBILIZUMAB-CDON Alternatives Have Lower Off label use Risk?
INEBILIZUMAB-CDON vs INEXIUM
INEBILIZUMAB-CDON vs INFLIXIMAB
INEBILIZUMAB-CDON vs INFLIXIMAB-ABDA
INEBILIZUMAB-CDON vs INFLIXIMAB-AXXQ
INEBILIZUMAB-CDON vs INFLIXIMAB-DYYB